Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Brief Summary: The objective of this study is to evaluate the efficacy and safety of vilanterol inhalation powder administered once daily in the evening in adolescent and adult subjects 12 years of age and older with persistent asthma over a 12-week treatment period.


Options:
A: Arm Label: Vilanterol; Type: EXPERIMENTAL; Interventions: Drug: Vilanterol, Drug: Placebo Inhalation Powder Diskus | Arm Label: Salmeterol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Salmeterol Inhalation Powder, Drug: Placebo Inhalation Powder NDPI | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Inhalation Powder NDPI, Drug: Placebo Inhalation Powder Diskus | Intervention Type: DRUG; Name: Vilanterol; Assigned to Arm(s): Vilanterol | Intervention Type: DRUG; Name: Salmeterol Inhalation Powder; Assigned to Arm(s): Salmeterol | Intervention Type: DRUG; Name: Placebo Inhalation Powder NDPI; Assigned to Arm(s): Placebo, Salmeterol | Intervention Type: DRUG; Name: Placebo Inhalation Powder Diskus; Assigned to Arm(s): Placebo, Vilanterol
B: Arm Label: Placebo MDPI; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo MDPI | Arm Label: Fp MDPI 25 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Propionate | Arm Label: Fp MDPI 50 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Propionate | Arm Label: FS MDPI 50/12.5 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Propionate/Salmeterol | Intervention Type: DRUG; Name: Fluticasone Propionate; Assigned to Arm(s): Fp MDPI 25 mcg BID, Fp MDPI 50 mcg BID | Intervention Type: DRUG; Name: Fluticasone Propionate/Salmeterol; Assigned to Arm(s): FS MDPI 50/12.5 mcg BID | Intervention Type: DRUG; Name: Placebo MDPI; Assigned to Arm(s): Placebo MDPI
C: Arm Label: FLOVENT™ DISKUS™ 100 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT™ DISKUS™ 100 mcg BID | Arm Label: ADVAIR™ DISKUS™ 100/50 mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR™ DISKUS™ 100/50 mcg BID | Intervention Type: DRUG; Name: FLOVENT™ DISKUS™ 100 mcg BID; Assigned to Arm(s): FLOVENT™ DISKUS™ 100 mcg | Intervention Type: DRUG; Name: ADVAIR™ DISKUS™ 100/50 mcg BID; Assigned to Arm(s): ADVAIR™ DISKUS™ 100/50 mcg
D: Arm Label: ADVAIR 100/50mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR 100/50mcg | Arm Label: ADVAIR 250/50mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR 250/50mcg | Arm Label: ADVAIR 500/50mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR 500/50mcg | Arm Label: FLOVENT 100mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT 100mcg | Arm Label: FLOVENT 250mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT 250mcg | Arm Label: FLOVENT 500mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT 500mcg | Intervention Type: DRUG; Name: ADVAIR 100/50mcg; Assigned to Arm(s): ADVAIR 100/50mcg | Intervention Type: DRUG; Name: ADVAIR 250/50mcg; Assigned to Arm(s): ADVAIR 250/50mcg | Intervention Type: DRUG; Name: ADVAIR 500/50mcg; Assigned to Arm(s): ADVAIR 500/50mcg | Intervention Type: DRUG; Name: FLOVENT 100mcg; Assigned to Arm(s): FLOVENT 100mcg | Intervention Type: DRUG; Name: FLOVENT 250mcg; Assigned to Arm(s): FLOVENT 250mcg | Intervention Type: DRUG; Name: FLOVENT 500mcg; Assigned to Arm(s): FLOVENT 500mcg

Answer: A